Latest ArticlesIn this study, a dual-ligand metal-organic framework(CB-MOF) material was prepared via a solvent evaporation method using potassium ions as the inorganic metal center and cyclodextrin together with benzenetricarboxylate as the composite organic ligands. The obtained CB-MOF was then used to encapsulate allicin(1), yielding the drug-loaded MOF(1@CBM). Subsequently, the microstructure and physicochemical properties of both CB-MOF and 1@CBM were comprehensively characterized by means of SEM, UV, TGA, FT-IR, and specific surface area and porosity analysis. Meanwhile, the drug loading capacity and cumulative in vitro drug release were quantitatively determined,and the antioxidant capacity and antimicrobial activity were evaluated through in vitro tests. The results showed that CB-MOF exhibited excellent loading capacity for 1, with a drug loading of 13.66%, and demonstrated favorable sustained-release characteristics in vitro. Furthermore, 1@CBM not only possessed significant antioxidant activity but also showed broad-spectrum antimicrobial effects against both bacteria and fungi, with significantly lower MIC values against Escherichia coli, Staphylococcus aureus, and Candida albicans compared with those of free 1. Combined with good biocompatibility, these properties provide a foundation for its application in the biomedical field.
This study systematically investigated the effects of formulation properties(the mass ratio of trehalose to L-leucine) in the precursor liquid, the atomizer types(ultrasonic atomizer and two-fluid atomizer), freezing temperatures(-40 and -60 ℃), and freezing methods(self-developed spray freezing tower and liquid nitrogen freezing) on the in vitro delivery performance of resveratrol inhalable liposomal powder. The hydrodynamic size,ζ potential, and percent drug retention of resveratrol liposomes were thoroughly investigated after mixing, atomization,freezing and rehydration after drying. Furthermore, the morphology and geometric diameter of the particles were thoroughly evaluated. The results revealed that atomization of resveratrol suspension formulated with trehalose and L-leucine at a mass ratio of 7∶3 using a twin-fluid atomizer followed by spray freezing at -40 ℃ yielded inhalable liposomal powder with good in vitro delivery and minimized drug leakage upon spray freeze-drying.
The formulation of upadacitinib(1) cream was investigated by a single-factor experiment, and its skin retention and permeation of 1 from the optimal cream were evaluated using Bama miniature pig skin as a model.Furthermore, its pharmacodynamic effects on mice with atopic dermatitis were also examined. The composition of the final optimized formulation was as follows: 2.0% of 1, 10.0% of white petrolatum, 10.0% of phosphate ester self-emulsifying wax, 5.0% of isopropyl palmitate, 20.0% of diethylene glycol monoethyl ether, 4.0% of 1,2-propylene glycol,0.2% of methylparaben, 0.05% of propylparaben, and 0.05% of EDTA-2Na. Stability study results showed that the cream formulations with drug loadings of 0.6% and 2.0% met the requirements for content, related substances, and physical form after 6 months of accelerated testing, demonstrating good stability. In vivo pharmacodynamic results demonstrated that the cream was superior to betamethasone cream in reducing ear swelling and alleviating skin lesions in mice. The formulation and manufacturing process were stable and controllable, and the product had a favorable efficacy, providing a basis for the development and application of 1 as a topical formulation.
An HPLC method for analyzing impurities in suvorexant bulk drug was established. Chromatographic separation was carried out on a Waters XBridge C18 column(4.6 mm × 250 mm, 3.5 μm) with a mobile phase consisting of 0.1% trifluoroacetic acid solution and acetonitrile for gradient elution. The flow rate was set at 1.0 mL/min, the column temperature was maintained at 50 ℃, the detection wavelength was 254 nm, and the injection volume was 15 μL. The chromatographic peaks of 1 and its seven known process impurities(SM3, M1, B, C, D, E, and F) exhibited good resolution.Baseline separation was achieved between 1 and its adjacent impurities, as well as among all impurity peaks. Good linear relationships were observed between the peak areas and the mass concentrations of the seven impurities, with linear correlation coefficients all above 0.9990. The average recoveries were 97.5% - 100.8% with the RSDs of 0.6% - 2.2%.This method is sensitive, simple and accurate for the simultaneous determination of seven impurities in 1 bulk drug.
An ICP-MS method was established for the simultaneous determination of 7 elemental impurities,namely lead, cadmium, arsenic, mercury, cobalt, vanadium and nickel in glipizide bulk drug. Samples were digested by microwave digestion, then the 7 elemental impurities were simultaneously determined by ICP-MS with internal standard method. The results showed that each elemental impurity had a good linear relationship between the mass concentration and the response value within the respective range(r>0.999), with LODs of 0.001 5 - 0.126 6 ng/mL, and LOQs of 0.005 0 -0.422 0 ng/mL. The recovery rates were 90.46%-103.25%, with RSDs(n=9) of 2.10%-4.47%. The method is simple,sensitive, and accurate, which can provide a reference for the control of elemental impurities in chemical drugs.